--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

6-month report

Subtitle: - EBIT expanded by over 50 percent to EUR 5.0 million -
Revenue increased to EUR 96.8 million - Occupancy rate with 88.6
percent above market average - Forecast of approximately EUR 10.0
million EBIT for whole fiscal year confirmed

Hamburg (euro adhoc) - 13 February 2012 - According to today´s
reported results for the first half of fiscal year 2011/2012 (July 1
to December 31, 2011) Marseille-Kliniken AG increased its
profitability significantly. The occupancy rate increased to 88.6
percent (Q2 2010/2011: 86.9 percent). Therefore revenues expanded to
EUR 96.8 million (previous year: EUR 95.2 million) and EBIT increased
from EUR 3.2 million to EUR 5.0 million. "With these results we
continue the improvement of our profitability. The Company is on
track for reaching our guidance for full fiscal year 2011/2012." says
Michael Thanheiser, chairman of Marseille-Kliniken AG.

Since fiscal year 2010/2011 Marseille-Kliniken AG fosters growth by a
strategy mix which includes a focus on care for elderly, quality
leadership and a decentralised management structure. Moreover an
initiative carried out to optimise costs also played a role in
supporting the company's economic recovery.

This trend continued in the results published today. With an increase
of 2.0 percent to 88.6 percent, the occupancy rate exceeded the
market average (88 percent).

Coincidently with the expansion of revenues, total expenses declined
from EUR 96.0 million in previous year to EUR 94.2 million. Due to
this EBITDAR increased by 1.5 percent to EUR 26.9 million (previous
year: EUR 26.5 million) and EBITDA rose by 15.3 percent to EUR 8.3
million (previous year: EUR 7.2 million). Total group earnings
increased to EUR 4.1 million (previous year: EUR 0.3 million). This
results in EUR 0.27 earnings per share (previous year: EUR 0.02).
Overall Marseille-Kliniken AG operates a total of 60 care facilities
across Germany, with a sales capacity of 7,953 beds on 31 December
2011.

Against the backdrop of the half yearly results, Marseille-Kliniken
AG confirms its forecast for full 2011/2012 financial year, which
calls for a slight revenue increase and Group EBIT of EUR 10.0
million, well above the previous year's level. The corresponding
report for the first half of fiscal year 2011/2012 is available to
the public today on the company's website at
www.marseille-kliniken.com.

---- End of press release ----

About Marseille-Kliniken AG:

Marseille-Kliniken AG with its 57 residential care facilities, three
residential units for assisted living and about 4,700 employees is a
market leading listed company on health care in Germany. The business
model is significantly influenced by the demographic development.
Therefore Marseille-Kliniken AG has a secured future. Short-term
economic fluctuations on the other hand exert only a minor influence.
As a consistently modern company, the firm is in a good position
within a competitive environment primarily determined by regionally
active charities.

Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.marseille-kliniken.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
Hamburg, regulated dealing/prime standard: Frankfurt
language: English

Quelle: OTS